UC-Riverside: Scientists Design New Drug to Fight Malaria
September 27, 2024
September 27, 2024
RIVERSIDE, California, Sept. 27 (TNSres) -- The University of California Riverside campus issued the following news:
* * *
MED6-189 is effective against drug-sensitive and drug-resistant strains of human malaria parasites
* * *
In 2022, nearly 619,000 global deaths due to malaria were caused by Plasmodium falciparum, the most virulent, prevalent, and deadly human malaria parasite. For decades, the parasite's resistance to all antimalarial drugs . . .
* * *
MED6-189 is effective against drug-sensitive and drug-resistant strains of human malaria parasites
* * *
In 2022, nearly 619,000 global deaths due to malaria were caused by Plasmodium falciparum, the most virulent, prevalent, and deadly human malaria parasite. For decades, the parasite's resistance to all antimalarial drugs . . .